|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
Executive Committee: Cornerstone Therapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Jon Zwinski
CEO | Chief Executive Officer | - | 2020-12-31 |
| Chief Tech/Sci/R&D Officer | 76 | - |
Company details: Cornerstone Therapeutics, Inc.
Generic Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.17% | +1.61% | +16.42% | +85.22% | 48.69B | |
| +1.04% | -1.02% | +69.47% | +115.88% | 36.38B | |
| -0.13% | -1.29% | -2.60% | +41.58% | 12.19B | |
| -0.71% | +0.89% | +18.28% | +97.87% | 12.04B | |
| -0.76% | +0.38% | +33.16% | +123.08% | 9.04B | |
| -0.86% | +0.37% | +52.61% | -3.54% | 7.06B | |
| +0.75% | -0.82% | +17.49% | +44.79% | 7.09B | |
| +0.69% | +3.25% | +19.90% | +243.91% | 6.75B | |
| +5.45% | -7.36% | -17.93% | +13.17% | 6.1B | |
| Average | +0.59% | -0.42% | +22.98% | +84.66% | 16.15B | |
| Weighted average by Cap. | +0.34% | +0.09% | +29.83% | +90.70% |
- Stock Market
- Stocks
- Stock
- Company Cornerstone Therapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
